BioSpace News Archive

Edesa Biotech, Inc. announced that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to participate in a virtual event at the 2022 OBIO Investment Summit hosted by the Ontario Bioscience Innovation Organization.

Cyclerion Therapeutics, Inc. today announced that patient dosing has begun in its Phase 2a study in Alzheimer’s Disease with Vascular Pathology (ADv).

SetBone Medical Ltd. announced today that it has closed an oversubscribed investment round of $1.6 million.

TetraScience, the R&D Data Cloud company, announced today that Datagrok, a web-based data analytics platform used by some of the largest pharmaceutical companies globally, has joined the Tetra Partner Network (TPN) to enable customers to utilize TetraScience’s Tetra Data as a trusted source for data-driven advanced analytics.

Artio Medical, Inc. today announced that Megan Giorgini has joined the company as Senior Director of Human Resources.

Concentric Analgesics, Inc. today announced the closing of a $20 million convertible note financing from a combination of new and existing investors.

As of January 1, 2022 , Essity’s business areas are Health & Medical, Consumer Goods and Professional Hygiene.

TYME Technologies, Inc. today announced the discontinuation of SM-88 with MPS in the Precision Promise trial in metastatic pancreatic cancer.

Third fiscal quarter 2021 total revenues of $54.4 million, including net product revenue of $29.3 million Net product revenue from U.S. sales of ORGOVYX ® of $24.4 million.

Second quarter revenue of $18.9 million increased 11% from the prior year and 36% sequentially.